Shiqiong Huang

Dec 31, 2024 | journals.plos.org | Shiqiong Huang

Loading metrics Open Access Peer-reviewedResearch Article Citation: Sun J, Deng X, Huang J, He G, Huang S (2024) Data mining of adverse drug event signals with Nirmatrelvir/Ritonavir from FAERS. PLoS ONE 19(12): e0316573. https://doi.org/10.1371/journal.pone.0316573Editor: Jingyu Wang, Peking University First Hospital, CHINAReceived: September 17, 2023; Accepted: December 12, 2024; Published: December 31, 2024Copyright: © 2024 Sun et al.

Sep 14, 2023 | paperity.org | Lin Hu |Shiqiong Huang |Qi Huang |Juanjuan Huang

PLOS ONE, Sep 2023 The aim of this study was to evaluate factors that impact on voriconazole (VRC) population pharmacokinetic (PPK) parameters and explore the optimal dosing regimen for different CYP2C19 genotypes in Chinese paediatric patients. PPK analysis was used to identify the factors contributing to the variability in VRC plasma trough concentrations. A total of 210 VRC trough concentrations from 91 paediatric patients were included in the study.

Sep 11, 2023 | journals.plos.org | Lin Hu |Qi Huang |Shiqiong Huang

Loading metrics Open Access Peer-reviewedResearch Article Citation: Hu L, Huang S, Huang Q, Huang J, Feng Z, He G (2023) Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients. PLoS ONE 18(9): e0288794. https://doi.org/10.1371/journal.pone.0288794Editor: Felix Bongomin, Gulu University, UGANDAReceived: April 12, 2023; Accepted: July 4, 2023; Published: September 11, 2023Copyright: © 2023 Hu et al.